Search results
We sought to compare the short-term success of great saphenous vein (GSV) ablation with VENCLOSE as compared with ClosureFast, determined by 2 consecutive postprocedure duplex ultrasounds (DUS). We also compared the occurrence of negative outcomes, treatment times, and number of RFA cycles performed.
The VenaSeal closure system (VenaSeal system) is indicated for use in the permanent closure of lower extremity superficial truncal veins, such as the great saphenous vein (GSV), through endovascular embolization with coaptation.
Introduction Endovenous ablations are the new standard procedures for treatment of great saphenous vein reflux including endovenous laser ablation (EVLA), radio frequency ablation (RFA), endovenous steam ablation (EVSA), mechanochemical ablation (MOCA), cyanoacrylate injection and ultrasound-guided foam sclerotherapy (UGFS).
29 lip 2015 · The VeClose Trial is a three-year long clinical evaluation of VenaSeal and ClosureFast, two of the newest saphenous vein treatment solutions on the market today.
Objective: The proprietary cyanoacrylate closure (CAC) system vs radiofrequency ablation (RFA) trial (VenaSeal Sapheon Closure System Pivotal Study [VeClose]) showed that CAC, a nontumescent, nonthermal, nonsclerosant ablation technique, was effective and noninferior to RFA in vein closure with good 36-month outcomes.
VSCS, utilizing a proprietary cyanoacrylate adhesive, offers a safe and effective method of treating refluxing saphenous veins without the need for tumescent anesthesia or postprocedure compression.*
30 sie 2012 · Endovascular obliteration of the great saphenous vein (GSV) has been proposed as an alternative to conventional extirpative treatment of varicose veins. This report reviewed the initial experience with the ClosureFAST™ procedure in 407 legs over a one-year period.
